Filing Details

Accession Number:
0001209191-14-053921
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2014-08-21 20:33:05
Reporting Period:
2014-06-10
Filing Date:
2014-08-21
Accepted Time:
2014-08-21 20:33:05
Original Submission Date:
2014-06-12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1299130 Pacific Biosciences Of California Inc. PACB Laboratory Analytical Instruments (3826) 161590339
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1503381 W. William Ericson C/O Mohr Davidow Ventures
3000 Sand Hill Road, #3-290
Menlo Park CA 94025
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-06-10 68,921 $5.21 4,667,318 No 4 P Indirect MDV VII LP, nom for MDV VII LP, MDV VII Leaders' Fund LP, MDV ENF VII (A) LP, and MDV ENF VII (B) LP
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect MDV VII LP, nom for MDV VII LP, MDV VII Leaders' Fund LP, MDV ENF VII (A) LP, and MDV ENF VII (B) LP
Footnotes
  1. Seventh MDV Partners, L.L.C. is the general partner of (i) MDV VII, L.P., as nominee for MDV VII, L.P., MDV VII Leaders' Fund, L.P., MDV ENF VII(A), L.P, and MDV ENF(B), L.P., (ii) MDV VII, L.P., (iii) MDV ENF VII (A), L.P., (iv) MDV ENF VII (B), L.P. and (v) MDV VII Leaders' Fund, L.P. (the "MDV VII Funds") and has sole voting and investment power over the shares. William Ericson is a general partner with Mohr Davidow Ventures, and may be deemed to indirectly beneficially own the shares affiliated with the MDV VII Funds. Mr. Ericson disclaims beneficial ownership of the shares held by the MDV VII Funds except to the extent of any pecuniary interest therein.